Iulian studied physics at the University of Bucharest, and he sees himself as a physicist in the broadest sense of the word. He also studied economics at Charles University in Prague and Central European University in Budapest, after a master’s program in business administration at Bucharest Academy of Economic Studies. Since recently, he’s been exploring coding and data analysis for business and economics. As a freelancer, he worked for nearly two decades as an analyst for ISI Emerging Markets, Euromonitor International, Business New Europe, but also as a consultant for OMV Petrom and UkrAgroConsult. Iulian was part of the founding team of Ziarul Financiar. At Romania Insider, which he joined in 2018, he is reviewing the latest economic developments for the premium bulletins and newsletters. He would gladly discuss topics such as macroeconomics, emerging markets, Prague, energy sector including renewable, Led Zeppelin, financial services, as well as tech start-ups and innovative technologies. Email him at iulian@romania-insider.com.
Hungarian company Alpin Szig es Szerkezet Epitoipari, through its wholly-owned Romanian subsidiary
The Municipality of Bucharest (PMB) completed the issuance and placement of bonds with a total
Restart Energy One, a Romanian provider of renewable energy solutions with two bond issues listed at
Eximprod Group, controlled by two Romanian investors, announced the completion of a 50 MW
Romania's industrial output contracted by 2.1% m/m (seasonally-adjusted terms) and 5.2% y/y in
The upward trend of the annual dynamics of industrial producer prices for consumer goods that had
Romania's competition body, Consiliul Concurentei, expressed eight concerns in a press release on
OMV Petrom (BVB: SNP), the largest integrated energy producer in South-Eastern Europe, in
Romanian cement producer Romcim, owned by the Irish group CRH, has completed the acquisition of two
The conventional electricity producers and the power distribution companies are preparing to
Romania’s automobile production decreased by 11.2% y/y to 135,723 units in Q1, according to data
Leventer Medical Group, a leading dermato-oncology center in Southeast Europe and a pioneer of Mohs